B7VKH2 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifranutptfzggoltj6xui6lzudncr72jmdfgi5huviiu3fuhikjby/metadata.json
IPFS of structure file: 
bafybeiablqem6by2ydsrnad46n52ettpq7nyuoa3vyahqjvlf24kkkuuue/AF-B7VKH2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6a3E2329d7c8AC20c4D0EC099eda7556d5C5b2b5
First NFT owner address (bech32): 
genesis1dglzx2whezkzp3xsasyeakn42m2utv44wek48q
Current NFT ID #166974 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
166974
Accession (UniProt):
B7VKH2
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Vibrio atlanticus (strain LGP32)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B7VKH2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B7VKH2|HEM1_VIBA3 Glutamyl-tRNA reductase OS=Vibrio atlanticus (strain LGP32) OX=575788 GN=hemA PE=3 SV=1 MSLLAVGINHNTASVELREKVAFGPDKLSEALKQLNANAHVNGSVILSTCNRTEVYCDVKGVAKNKLIDWLSVFHQVSPEELKPSIYIHEEQAAIKHLMRVACGLDSLVLGEPQILGQVKQAYTDSRDNKSVDASMEKLFQKSFSVAKRVRTETEIGGSAVSVAYAACTLAKHIFESIAESTVLLVGAGETIELVAKHLSANGCTKMIVANRTRERALGLAEEFGAEVISLNEIPDHLHRADIVISSTASPLPIIGKGMVETALKTRKHQPMLLVDIAVPRDVESQVGDLNDAYLYSVDDLQSIVDGNIEQRKVEAIQAEAIVSEESAAFMSWMRSLQAVDSIRDYRKSANEIREELLSKSLQSLAAGGDPEKVLLELSNKLTNKLIHAPTRALQSAAEQGEPAKLTVIRQSLGLENPQ